|1.||Takeda, Shuichi: 1 article (01/2010)|
|2.||Maruyama, Hirofumi: 1 article (01/2010)|
|3.||Takeda, Hiroshi: 1 article (01/2010)|
|4.||Hattori, Tomohisa: 1 article (01/2010)|
|5.||Sadakane, Chiharu: 1 article (01/2010)|
|6.||Inagaki, Yayoi: 1 article (01/2010)|
|7.||Koseki, Junichi: 1 article (01/2010)|
|8.||Shindo, Shoichiro: 1 article (01/2010)|
|9.||Hasegawa, Yoshihiro: 1 article (01/2010)|
01/01/2010 - "We also investigated the effect of TJN-419 on erosion in the rectum in a DSS-induced colitis model in rat. "
01/01/2010 - "These results indicate that IL-12 has a possible role in development of DSS-induced colitis and that TJN-419 is effective for treatment of this disease model via inhibition of IL-12 production."
01/01/2010 - "TJN-419 also inhibited the increase in IL-12 and suppressed the area of erosion in the rectum in DSS-induced colitis in rats. "
01/01/2010 - "Intravenous injection of the anti-IL-12 antibody and oral administration of TJN-419 inhibited clinical symptoms in DSS-induced colitis. "
01/01/2010 - "We then assessed the effect of TJN-419 or a neutralizing antibody against murine IL-12 in a DSS-induced colitis model in C57 BL/6 mice. "
|1.||Interleukin-12 (IL 12)